In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Meet the Team
 
Lucie Ellis

Lucie Ellis

Executive Editor 
Lucie.Ellis@informa.com

@ScripLucie

Lucie has been covering the ups and downs of the pharmaceutical industry since joining the Informa Pharma Intelligence team in 2012. Prior to being Managing Editor of In Vivo, Lucie was a Senior Editor at Scrip and Pink Sheet. She is responsible for the production of In Vivo’s print and online editions and also contributes feature-length articles to the publication on the topics of leadership, R&D, innovation and more.

Read more »


Ben Comer

Pharma Editor 
Ben.Comer@informa.com

@BenMComer

Ben is Pharma Editor at In Vivo, responsible for biopharma industry coverage. His areas of focus include commercialization and R&D strategy, regulation, policy and social issues impacting the sector. Prior to joining In Vivo, Ben was a Senior Manager at PwC’s Health Research Institute and a Senior Editor at Pharmaceutical Executive magazine.

Read more »


Ashley Yeo

Medtech Editor
ashley.yeo@informa.com

@ashleypyeo

 

Ashley Yeo delivers content that gives insight into current and future trends in the global medtech industry, and what players need to do, and with whom, to keep ahead of the game in this fast-evolving and highly competitive sector. He currently writes for In Vivo and Medtech Insight as an Executive Editor. Ashley has been with Informa and legacy publications, reporting on all forms of healthcare (plant, animal, human) for over 30 years, having joined as a linguist on the European desk and later becoming editor of three diverse publications. He has also contributed aesthetic medicine and pharma content when a member of the multifunctional team of pharma analysts. His current focus is the strategic rationale of the big players in medtech, on In Vivo; and UK, European and OUS global regulation and policy input on Medtech Insight..

Read more »

 

Deanna Kamienski

Senior Deals Analyst, Biomedtracker
Deanna.Kamienski@informa.com

Deanna has been tracking deal-making activity in the biopharma and medtech industries since 2000. She is currently a Senior Deals Analyst for Biomedtracker and had previously contributed to the Strategic Transactions deals database. Deanna authors a Quarterly Statistics article and other monthly trend pieces for In Vivo. She holds a Bachelor of Science degree from the University of Vermont.

 

 

Read more »


Maureen Riordan

Senior Deals Analyst, Biomedtracker
Maureen.Riordan@informa.com

 

Currently a Senior Deals Analyst with Biomedtracker and previously a contributor to the Strategic Transactions deals database, Maureen has been reporting on deal-making activity and trends since 1996. She also authors a quarterly deal-making statistics article and other monthly trend pieces for In Vivo. Maureen holds a Bachelor of Arts degree in English from Niagara University, and a Master of Library Science degree from Southern Connecticut State University.

 

 

Read more »


 

 

Karen Coleman

Head of Editorial Ops
karen.coleman@informa.com

Karen is the Head of Editorial Operations for In Vivo, Pink Sheet, Scrip and Generics Bulletin working with a global team of expert, experienced and respected journalists. She qualified as a pharmacist in South Africa in 2000 where she worked in retail and hospital settings before relocating to the UK in 2002. Karen spent nine months working for the NHS in a variety of hospital pharmacy settings, including Moorfields Eye Hospital. In December 2002 she joined IMS Health (now IQVIA), analyzing patent expiries and generic drug launches in 26 major and emerging markets. Karen joined Informa in 2009, leading a team of analysts publishing Strategic reports covering numerous aspects of the Pharma and Medtech industries. She has held a number of management and leadership roles over the years, ensuring the successful delivery of product enhancements and consolidation, and process improvements, working closely with Editorial, Technical and Commercial teams.

UsernamePublicRestriction

Register